KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Receivables - Net (2017 - 2025)

Historic Receivables - Net for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $894.0 million.

  • Elanco Animal Health's Receivables - Net rose 642.86% to $894.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $894.0 million, marking a year-over-year increase of 642.86%. This contributed to the annual value of $805.0 million for FY2024, which is 439.43% down from last year.
  • According to the latest figures from Q3 2025, Elanco Animal Health's Receivables - Net is $894.0 million, which was up 642.86% from $989.0 million recorded in Q2 2025.
  • Elanco Animal Health's Receivables - Net's 5-year high stood at $1.1 billion during Q2 2021, with a 5-year trough of $797.0 million in Q4 2022.
  • For the 5-year period, Elanco Animal Health's Receivables - Net averaged around $927.9 million, with its median value being $924.0 million (2021).
  • In the last 5 years, Elanco Animal Health's Receivables - Net soared by 9617.58% in 2021 and then tumbled by 1415.18% in 2022.
  • Quarter analysis of 5 years shows Elanco Animal Health's Receivables - Net stood at $833.0 million in 2021, then decreased by 4.32% to $797.0 million in 2022, then rose by 5.65% to $842.0 million in 2023, then decreased by 4.39% to $805.0 million in 2024, then grew by 11.06% to $894.0 million in 2025.
  • Its Receivables - Net stands at $894.0 million for Q3 2025, versus $989.0 million for Q2 2025 and $970.0 million for Q1 2025.